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Porcine pancreatic group 1 phospholipase A., (PLA:-I) indaced contraction of guinea pig lung parench),ma in a concentration.dependent ma ner. 
Its EC~ value was similar to the Kd value calculated from the specific binding of t'Sl-lab¢led porcine PLA2-I in the membrane fraction of guinea 
pig lung. Type-specific action of PLA,'s and homologous desensitization strongly implicated the involvement of PLA:.I.spccific sites in the 
activation process. Thrombosane A, was found to be the main product from lung tissue by PLA:.I action and the contractile r sponse by PLA,-I 
was specifically suppressed by thromboxan¢ A2 receptor antagonists and cyclooxygenase inhibitor, but not by leukotriene receptor antagonist and 
HI blocker. These findings indicate that PLA,-I-induced contractile response may depend on the secondarily produeed thromboxane A:, thus 
providing a new aspect of PLA,-I from the pathophysiological standpoint. 
Phospholipas¢ A2; Specific binding site; Thromboxane A:; Guinea pig lung parenchyma; Contraction; (÷).S-145Na 
1. INTRODUCTION 
Mammalian extracellular phospholipase A, (PLA:) 
can be classified into two types, pancreatic group I 
(PLA,-I) and arthritic group II (PLA2-II), based on 
their primary structures [1]. PLA~.-I is mainly secreted 
from the pancreas and has long been thought to be a 
digestive nzyme [2]. However, we recently found a pro- 
tein specifically binding PLA2-I (M, .-- 190,000) in mem- 
branes of various cells and tissues including those of 
human origin [3,4]. We also reported that PLA:-I di- 
rectly stimulated DNA synthesis in Swiss 3T3 cells [4], 
rat synovial and vascular smooth muscle cells [3], and 
also induced chemokinetic migration in rat embryonic 
aortic smooth muscle cells (A7rS) [5]. These findings 
strongly implicate PLA.~-I in the modulation of cellular 
functions with respect to some pathophysiologica! 
states. Further evidence for the presence of PLA.,-I in 
several tissues, such as lung, kidney and small intestine 
[6-9], prompted us to examine PLA,-I for other physio- 
logical functions in these tissues. In this study we have 
characterized the PLA,.-I-specific binding sites in guinea 
pig lung parenchyma nd examined the effect of PLA2-I 
from the pathological standpoint. 
Abbreviations: PLA_,, phospholipas¢ A2; ACh. acctylcholine; TxBa, 
thromboxane B,_; IN3D2, prostaglandin D2; LT, leukotrien¢. 
Correspondence address: H. Arita, Shionogi Rescarcll Laboratories, 
Shionogi & Co, Ltd., 12.4 Sagisu 5-ehome. Fukashima-ku, Osaka 553, 
Japan, 
2. MATERIALS AND METHODS 
2.1. Materials 
Preparation of various PLA,'s and iodination of porcine PLA,-I 
were carried out as described previously [3,41. The sodium salt of 
(+)-S-145 ((+)-S-145Na) [10], ONO3708 [111 and FPL55712 [12] were 
synthesized in our laboratories, r~rilamine, indomatha~in a ti ace. 
tylcholine chloride (ACh) were purchased from Sigma (St. Louis, 
MO). 
2,2, Crude menzbrane preparation from guinea pig lung ti~ue 
Male guinea pigs weighing 300-600 g (Charle~ River Japan Inc., 
Kanagawa. Japan) were sacrificed by stunning and ezsanguination. 
The lungs were removed and homogenized in 4 vols. of buffer A (20 
mM Tris/HCI, pH 7,4, 2 mM EDTA, 0,4 mM phenyimethylsulfonyl 
fluoride, 10/zg/ml eupeptin and 0.25 M sucrose), The homogenate 
was centrifuged at 3,000 x g for 20 rain, The supematant was then 
centrifuged at 105,000 x g for 60 rain. The pellets were resuspended 
in buffer A, dispersed by gentle homogenization, a d stored at -80*C 
until assay. 
2,3. Binding e.xperiJnents 
The binding experiments were performed by incubating lung mem- 
branes with various concentrations of porcine [t:Sl]PLA2-I in a total 
volume of 0,2 ml of buffer B (20 mM Tris/HCI, pH 7.4, 2 mM I~DTA 
and 0.1% BSA) at 4oc for 2 h. Specific binding was defined as the 
difference between binding in the presence and absence of the unla. 
beled porcine PLA~.I (500 riM). After the incubation the radioactivity 
in the membrane was analyzed as reported previously [4]. The specific 
binding was 8-~% of the total binding. Competition enperiments were 
performed by incubating the membranes with 3 nM porcine 
[t~IIPLA,-I in the presence of 100 nM of PLA:'s under similar binding 
conditions. 
2,4. Contractile activity on g~tinea pig I~g parenehymal strtp~ 
Lungs from guinea pigs were removed and perfused with Kreb's 
solution (composition, raM: MaCl i 18.0; KCl 4.7; CaCl2 2.5; KH.PO~ 
1,2; NaHCO~ 25.0; MgSO~ • 7H20 1.2; .~nd g!~o~ 10.0) until free of 
blood. Lung parcnchymal strips were carefully cut from the distal 
edges of the lower lung lobes (approximately 3 x 1 x 20 ram) and 
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suspended in an organ bath containing 10 ml of Krcb's solution 
maintained at 37°C and gassed continuously with 95% Oa and 5% 
CO:. Tissue contractions were recorded isometrically using force 
transducers (Nihon Kohden TB61 IT, Japan). The tissues were al- 
lowed to ~qailibrate for at least 60 rain under a resting tension oi"0.5 
g, and then constant maximal contractions to ACh (l raM) were 
obtained before the additions of porcine PLA,-I at varying concentra- 
tions. For pharmacological studies on porcine PLA~-l-induced con. 
tractions, the strips were pre-incubated with several drugs before add- 
ing PLA~-I, To minimize inter-tissue variability the contractile re- 
spon~ was expressed relative to the contraction elicited by the 1 mM 
ACh. 
2.5. Porcine PLA:.l-induced mediator synthesis and release from 
guinea pig lu~tg tissue 
Lungs were removed and rinsed in Kreb's solution then minced into 
1-2 mm ~ pieces with a razor. The minced lung (0.1 g/ml) was incubated 
with porcine PLA,-I at 10 nM (unless otherwise stated) or vehicle in 
Kreb's solution at 370C for 1-30 mir~. The concentrations of throm- 
boxane B: (TxB:), prostaglandin D: (PGD,) and leukotriene (LT) 
C~/DJE4 in the sup~rnatant were measured by radioimmunoassay, 
and that of histamine was determined by HPLC [13], 
2,6. Sl~tistlos 
Statistical analysis was performed u~ing Student's t-test. 
3. RESULTS 
At various concentrations porcine PLA,.-I specifically 
bound to crude guinea pig lung membranes, of which 
the level of specific binding was about 85% of" total 
binding. The $catchard plot of the specific binding (Fig. 
1) is linear, indicating the presence of a single class of 
binding site with a/fd value of 3.3 nM and a maximal 
binding capacity (B~s) of 46,0 final/me protein. This K,~ 
value is similar to those reported for other cells and 
tissues that possess pecific PLA:-I binding sites [3]. The 
specific binding of [~:Sl]PLA.,-I to the lung membranes 
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Fig.t, Scatchard analysis of ['"q]PLA.,-I to crude membranes or 
guinea pig lung, The membranes were incubated in the presence or 
increasing concentrations of [ml]PLA.-I at 4°C for 2 h, Non-specilic 
binding in the presence of 500 aM of porcine PLA,,-i was subtracted 
from each point. The specific binding was 85% of the total binding. 
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Fig. 2. Typical tracings howing the contractile r sponse of guinea pig 
lung parenchymal strip to ACh and porcine PLA=-I. After maximal 
contraction i duced by 1 mM ACh (added at t = 0) was obtained, the 
tissue was washed with Kreb's olution and treated with 10 nM PLA:-I 
at r = 20 rain. After a fur/her 20 rain the tissue was washed and then 
1 mM ACh and 10 nM PLA:-I were subsequently added to the organ 
bath again at the indicated time. 
was completely inhibited by porcine, human and rat 
PLA.,-I (100 nM), but was not affected by PLA2-II's 
purified from rat and rabbit platelets and rat and 
human PLA:-I zymogens (data not shown), indicating 
that guinea pig lung has a specific binding site for the 
mature form or mammalian PLA.,-I, as is the case for 
several rat preparations [3,4]. As shown in Fig. 2 por- 
cine PLA:-I (10 riM) elicited a slow contraction of 
guinea pig lung parenchymal strips. The contraction 
reached a plateau 5-10 rain after the addition of PLA:-I, 
and then declined slowly. After washing with Kreb's 
solution and returning to the baseline level the same 
amount of PLA:-I was again added but no further con- 
traction occurred, although the response to ACh re- 
mained unchanged. As can be seen in Fig. 3, the EC~0 
value (the PLA,-I concentration giving a half-maximal 
response) was about 4 nM, a value which is similar to 
the Kd value (3.3 riM) for PLA2-I binding. The maximal 
Table I 
Pharmacological modulation of porcine PLA,-l-indueed contractile 
response of guinea pig lung parenchyma 
Drugs Concentration it Contraction 
(M) (% of ACh) 
Vehicle 
(÷)-S-145Na 
ONO3708 
FPL$5712 
l~rilamine 
lndomethacin 
12 61.3 ± 4.8 
1 x 10 -~ 4 28,2 + 4.0** 
3 x 10 -° 4 17.4 ± 3.0** 
I x I0 -a 6 5.5 _ 1.7"* 
l x 10 -7 3 23.9 ± 3.3** 
1 × 10 -~ 8 61.7 ± 4.5 
1 x 10 -6 4 70.9 _+ 5.9 
I x 10 -s 3 14.8 ± 2.0** 
Lung parenchymal strips were pre-incubated with (+).S.145Na, 
ONO3708, FPL55712, pyrilamine or indom¢thacin for 30 rain, 30 rain, 
20 rain, 5 rain and 30 rain, respectively. Then tissues were challenged 
consecutively with 10 nM porcine PLA:-I. The contra,'tile r sponses 
are expressed as a percentage of maximal response induced by I mM 
ACh. Each value represents the mean + S,E.M. or the indicated num- 
ber (n) of experiments. "*Statistical signillcant from vehicle at 
P< 0,01, 
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Fig, 3. Concentration-response curve for contractile responses of 
guinea pig lung parenchyraa to porcine PLA,-I (o), rat PLA.-II (A), 
and the zylnogen of porcine PLA,-I (n). To minin~iz= inter-tissue 
variability the contractile r sponses are expressed asa percentage of 
the maximal response induced b~/ 1 raM ACh. Each point represents 
the means __S.E.M., it -- 4. 
response to PLA2-I was 50-70% of that to ACh. Neither 
porcine PLA:-I zymogen nor rat PLA_,-II at 30 nM 
induced contraction significantly. 
When lung parenchymal strips were pretreated with 
the TxA~ receptor antagonist (÷)-S-145Na or 
ONO3708, or the cyclooxygenase inhibitor indometha- 
cin, the maximal contractile response induced by 10 nM 
PLA,.-I was markedly attenuated (Table I). In contrast 
no significant inhibition was observed in the presence 
of the LT antagonist FPL55712 or the histamine antag- 
onist pyrilamine. It is, therefore, highly likely that 
PLA.,-I-iaduced contraction is mediated by TxA_, pro. 
duced by lung tissue in response to PLA2-1. 
In fact a marked increase in TxB, (stable metabolite 
of TxA:) release from chopped lung tissue was detected 
5 rain after the addition of 10 nM PLA:-I when marked 
contraction of lung strips was elicited. The treatment of 
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FiB. 4. Time-course of TxA, release from chopped guinea pig lung 
tissues by porcine PLA2-I. Tile l,,ng ['r'~sraents were pre-incubated for 
5 rain and then challenged with vehicle (o} or LO nM PLA~-I (1). After 
an appropriate incubation p~riod aportion was rcraovcd for determi- 
nation of TxB., (see section 2). Each point represents the mean _+ 
$.E.M., n = 4. 
lung tissue with 10 nM PLA2-1 for 5 rain also caused a 
significant release of LTC4/D,dE4 (control, 68.1 +_ 2.2; 
PLA:-I treatment, 111,6 _ 10.0: n = 4, P < 0.05), hut 
did not affect the release of PGD2 and histamine. In 
view of the pharmacological evidence obtained with the 
LT receptor antagonist i  is likely that the LT's released 
do not exert any direct effect on the contraction. 
4. DISCUSSION 
The present study indicates that PLA:-I exerts a po- 
tent contractile ffect in guinea pig lung parenchyma. 
This contraction was significantly attenuated by TxA, 
receptor antagonists and cyclooxygenase inhibitor but 
not b'.. HI blocker and/or LT receptor antagonist. These 
data, along with direct evidence of TxA2 release from 
lung tissue, clearly indicate that TxA., may play a major 
role in the parenchymal contraction by PLA2-I. 
Guinea pig lung was found to have specific binding 
sites for the mature type of mammalian PLA.,-I and its 
Kd value was almosi the same with an ECho value for 
PLA2-I-induced contraction. Rat PLA2-II and zymogen 
of porcine PLA,-I, which did not bind to the PLA,-I 
binding site, could not induce the contraction of lung 
parenchyma atconcenlrations up to 30 nM. In addition 
treatment of the lung parenchyma by PLA,-I (10 nM) 
followed by subsequent washing did not produce a re- 
sponse to the second challenge of PLA,-I (Fig. 2), 
whereas the responses by other types of agonists, such 
as histamine, ACh and TxA~ mimetic U46619, were not 
affected. This homologous desensitization, as well as 
type specific action of PLA2's, strongly suggests that 
PLA2-l-induced contraction is mediated via its specific 
receptor. Although the desensitization mechanism by 
PLA:-I remains obscure one possible xplanation is that 
it may be due to the rapid internalization of binding 
sites as has been found with cultured rat vascular 
smooth muscle cells [3]. PLA:-I initially binds to its 
specific binding site in some target cells which may acti- 
vate the arachidonic acid cascade within the cells to 
release TxA,. As one of the possible candidates for the 
target cells, alveolar macrophages, which are mostly 
rich in TxA2 synthase in lung [14], have been isolated 
from guinea pig, and examined for the effect of porcine 
PLA2-I. However, no PLA.,-I binding site was found 
and no TxA,, release was detected even when the cells 
had been treated with 100 nM porcine PLA,-I for 30 
rain. Furthermore, no liberation of frc¢ fatty acids from 
alveolar macrophages labeled with [~H]oleic acid or 
[3H]arachidonic a id was detected up to 1 ,uM concen- 
tration of porcine PLA2-I within 1 h, although 10,aM 
A23187 liberated a large amount of labeled fatty acids 
(data not shown). 
Mast cells in lung parenchyma may not be involved 
in this activation process because histamine and PGD, 
were not significantly released in the initial response to 
PLA:-I. Therefore, other types of pulmonary cciis, i.e. 
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fibroblast, endothelial or smooth muscle cells might be 
involved as the target cells of PLA2-I. 
In conclusion, our findings reveal a new aspect of 
PLA2-I action in lung as a possible mediator causing 
broncho-constriction in pulmonary diseases such as 
asthma [15]. We are now conducting further studies into 
its pathophysiological functions, as well as its target 
cells in lung tissue. 
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